The Current Ratio as of December 2025 (TTM) for OnKure Therapeutics, Inc. (OKUR) is 11.45

According to OnKure Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.45. This represents a change of 2.95% compared to the average of 11.12 of the last 4 quarters.

OnKure Therapeutics, Inc. (OKUR) Historical Current Ratio (quarterly & annually)

How has OKUR Current Ratio performed in the past?

The mean historical Current Ratio of OnKure Therapeutics, Inc. over the last ten years is 10.93. The current 11.45 Current Ratio has changed 10.38% with respect to the historical average. Over the past ten years (40 quarters), OKUR's Current Ratio was at its highest in in the September 2024 quarter at 23.71. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

OnKure Therapeutics, Inc. (OKUR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of OnKure Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OnKure Therapeutics, Inc. (OKUR) Average Current Ratio

How has OKUR Current Ratio performed in the past?

The current Current Ratio of OnKure Therapeutics, Inc. (OKUR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

OnKure Therapeutics, Inc. (OKUR) Current Ratio vs. Peers

How is OKUR’s Current Ratio compared to its peers?

OnKure Therapeutics, Inc.’s Current Ratio is greater than Tempest Therapeutics, Inc. (2.11), greater than Kezar Life Sciences, Inc. (7.29), greater than FibroGen, Inc. (1.04), greater than PDS Biotechnology Corporation (2.09), greater than Xilio Therapeutics, Inc. (2.20), greater than Actinium Pharmaceuticals, Inc. (7.96), greater than Aligos Therapeutics, Inc. (4.70), greater than Mersana Therapeutics, Inc. (1.39), greater than Barinthus Biotherapeutics plc (8.04), greater than CEL-SCI Corporation (0.47),

Build a custom stock screener for OnKure Therapeutics, Inc. (OKUR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OnKure Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OnKure Therapeutics, Inc. (OKUR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OnKure Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.